Company Filing History:
Years Active: 1985-1997
Title: Mark M Foreman: Innovator in Pharmaceutical Science
Introduction
Mark M Foreman is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical science, holding a total of 7 patents. His work focuses on innovative methods and formulations that address critical health issues.
Latest Patents
Among his latest patents is a method of preventing emesis using tetrahydrobenz. This invention provides methods for preventing emesis and treating sexual dysfunction in mammals by utilizing certain tetrahydrobenz[c,d]indoles. Additionally, he has developed tetrahydrobenz[c,d]indole serotonin agonists, which are 6-substituted-4-(amino or substituted amino)tetrahydrobenz[c,d]indole serotonin agonists useful in treating various conditions associated with serotonin function.
Career Highlights
Mark M Foreman is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to groundbreaking advancements in medication and treatment options.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Michael E Flaugh and William L Garbrecht. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Mark M Foreman exemplifies the spirit of innovation in pharmaceutical science through his patents and contributions to Eli Lilly and Company. His work continues to impact the field positively, addressing significant health challenges.